The following temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 23 and 24 October 2000. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no. If no objections are received, the new ATC codes and DDDs will be considered final and will be included in the January 2002 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy. |
ATC level |
INN/common name |
ATC code |
New ATC level codes (other than 5th level): |
Drugs acting on serotonin receptors |
|
A03AE |
Prostaglandins |
|
S01EE |
Streptogramins |
|
J01FG |
New ATC 5th level codes: |
| |
alosetron |
A03AE01 |
| |
benzethoniumchloride, combinations |
D08AJ58 |
| |
betacarotene |
A11CA02 |
| |
betaine |
A16AA06 |
| |
betamethasone |
S03BA03 |
| |
biphenylol |
D08AE06 |
| |
bisacodyl,combinations |
A06AB52 |
| |
carglutamic acid |
A16AA05 |
| |
caspofungin |
J02AX04 |
| |
doxycycline |
A01AB22 |
| |
drospirenoneandestrogen |
G03AA12 |
| |
dyclonine |
R02AD04 |
| |
dydrogesteroneandestrogen |
G03FA14 |
| |
epinephrine |
R01AA14 |
| |
ethanol |
D08AX08 |
| |
indium (111In)capromabpendetide |
V09IB04 |
| |
ioxilan |
V08AB12 |
| |
iproclozide |
N06AF06 |
| |
levetiracetam |
N03AX14 |
| |
linezolid |
J01XX08 |
| |
lopinavir |
J05AE06 |
| |
magnesium citrate |
A06AD19 |
| |
magnesium oxide |
A12CC10 |
| |
nifenazone |
M02AA24 |
| |
peginterferon alfa-2a |
L03AB11 |
| |
phenol |
R02AA19 |
| |
pyrithione zinc |
D11AX12 |
| |
quinupristin/dalfopristin |
J01FG02 |
| |
rasburicase |
V03AF07 |
| |
tegaserod |
A03AE02 |
| |
tramadol, combinations |
N02AX52 |
| |
unoprostone |
S01EE02 |
| |
zoledronicacid |
M05BA08 |
ATC code changes |
Previous: |
bupropion |
N06AX12 |
New: |
bupropion |
N07BA02 |
Previous: |
glatiramer acetate |
L04AA07 |
New: |
glatiramer acetate |
L03AX13 |
Previous: |
latanoprost |
S01EX03 |
New: |
latanoprost |
S01EE01 |
Previous: |
pristinamycin |
J01FA04 |
New: |
pristinamycin |
J01FG01 |
Change of name: |
Previous: Macrolidesandlincosamides |
|
|
New: Macrolides, lincosamides and streptogramins |
J01F |
Previous: |
amfebutamone |
|
New: |
bupropion |
N07BA02 |
New DDDs:
INN/common name |
DDD |
Unit |
Route of Administration |
ATC code |
alosetron* |
2 |
mg |
O |
A03AE01 |
atosiban |
165 |
mg |
P |
G02CX01 |
brinzolamide |
0.2 |
ml |
|
S01EC04 |
bupropion** |
0.3 |
g |
O |
N07BA02 |
dihydrocodeine |
0.15 |
g |
O |
N02AA08 |
esomeprazole |
20 |
mg |
O |
A02BC05 |
etanercept |
7 |
mg |
P |
L04AA11 |
infliximab |
3.75 |
mg |
P |
L04AA12 |
levetiracetam* |
2 |
g |
O |
N03AX14 |
levodropropizine |
0.12 |
g |
O |
R05DB27 |
meloxicam |
15 |
mg |
P |
M01AC06 |
nonacog alfa |
1000 |
U |
P |
B02BD09 |
protionamide |
0.75 |
g |
O |
J04AD01 |
quinupristin/dalfopristin* |
1.5 |
g |
P |
J01FG02 |
rifampicin |
0.6 |
g |
P |
J04AB02 |
ribavirine |
1 |
g |
O |
J05AB04 |
zoledronic acid* |
4 |
mg |
P |
M05BA08 |
* Temporary ATC code
** Temporary changed ATC code from N06AX12 to N07BA02